Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali

Background. In 2010, mass vaccination with a then-new meningococcal A polysaccharide–tetanus toxoid protein conjugate vaccine (PsA-TT, or MenAfriVac) was undertaken in 1- to 29-year-olds in Bamako, Mali. Whether vaccination with PsA-TT effectively boosts tetanus immunity in a population with heterog...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Infect Dis
Päätekijät: Basta, Nicole E., Borrow, Ray, Berthe, Abdoulaye, Onwuchekwa, Uma, Dembélé, Awa Traoré Eps, Almond, Rachael, Frankland, Sarah, Patel, Sima, Wood, Daniel, Nascimento, Maria, Manigart, Olivier, Trotter, Caroline L., Greenwood, Brian, Sow, Samba O.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2015
Aiheet:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639490/
https://ncbi.nlm.nih.gov/pubmed/26553691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ513
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia